CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 878 of 1
Non-Antibody Products
Page 878 of 1,304
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| 3'-O-(5-Bromoanthraniloyl)-2'-deoxyadenosine-5'-O-triphosphate (sodium salt) | A dATP derivative | 700 µg | 38814-700 | More Info |
| 3'-O-(5-Bromoanthraniloyl)-2'-deoxyguanosine-5'-O-triphosphate (sodium salt) | A dGTP derivative | 700 µg | 38815-700 | More Info |
| 2'(3')-O-(5-Bromoanthraniloyl)guanosine-5'-O-triphosphate (sodium salt) | GTP derivatives | 700 µg | 38816-700 | More Info |
| 2'(3')-O-(5-Bromoanthraniloyl)inosine-5'-O-triphosphate (sodium salt) | Fluorescent ITP derivatives; selectively inhibits mammalian AC1, AC2, and… | 3.5 mg | 38446-35 | More Info |
| Obscurolide A1 | Inhibits calcium / calmodulin-dependent phosphodiesterase from bovine brai… | 1 mg | 14439-1 | More Info |
| Obscurolide A1 | Inhibits calcium / calmodulin-dependent phosphodiesterase from bovine brai… | 5 mg | 14439-5 | More Info |
| Obtusifolin | An anthraquinone with diverse biological activities; prevents IL-1β-i… | 1 mg | 34757-1 | More Info |
| Obtusifolin | An anthraquinone with diverse biological activities; prevents IL-1β-i… | 10 mg | 34757-10 | More Info |
| Obtusifolin | An anthraquinone with diverse biological activities; prevents IL-1β-i… | 25 mg | 34757-25 | More Info |
| Obtusifolin | An anthraquinone with diverse biological activities; prevents IL-1β-i… | 5 mg | 34757-5 | More Info |
| OC000459 | A potent, selective DP2 antagonist (Kis = 13, 3, and 4 nM for human recomb… | 10 mg | 12027-10 | More Info |
| OC000459 | A potent, selective DP2 antagonist (Kis = 13, 3, and 4 nM for human recomb… | 25 mg | 12027-25 | More Info |
| OC000459 | A potent, selective DP2 antagonist (Kis = 13, 3, and 4 nM for human recomb… | 5 mg | 12027-5 | More Info |
| 1-O-Caffeoylquinic Acid | A phenolic acid; binds the NF-κB precursor protein p105 (Ki = 0.007… | 1 mg | 36189-1 | More Info |
| 1-O-Caffeoylquinic Acid | A phenolic acid; binds the NF-κB precursor protein p105 (Ki = 0.007… | 10 mg | 36189-10 | More Info |
| 1-O-Caffeoylquinic Acid | A phenolic acid; binds the NF-κB precursor protein p105 (Ki = 0.007… | 5 mg | 36189-5 | More Info |
| 5-O-Caffeoylquinic Acid | A phenolic compound; scavenges DPPH (EC50 = 0.184 mg / ml) and AAPH radica… | 10 mg | 25054-10 | More Info |
| 5-O-Caffeoylquinic Acid | A phenolic compound; scavenges DPPH (EC50 = 0.184 mg / ml) and AAPH radica… | 25 mg | 25054-25 | More Info |
| 5-O-Caffeoylquinic Acid | A phenolic compound; scavenges DPPH (EC50 = 0.184 mg / ml) and AAPH radica… | 5 mg | 25054-5 | More Info |
| 5-O-Caffeoylquinic Acid | A phenolic compound; scavenges DPPH (EC50 = 0.184 mg / ml) and AAPH radica… | 50 mg | 25054-50 | More Info |
| 2'(3')-O-(5-Chloroanthraniloyl)adenosine-5'-O-triphosphate (sodium salt) | Fluorescent ATP derivatives; an inhibitor of mammalian AC1, AC2, and AC5 (… | 3.3 mg | 38449-33 | More Info |
| 3'-O-(5-Chloroanthraniloyl)-2'-deoxyadenosine-5'-O-triphosphate (sodium salt) | A derivative of dATP | 600 µg | 38819-600 | More Info |
| 3'-O-(5-Chloroanthraniloyl)-2'-deoxyguanosine-5'-O-triphosphate (sodium salt) | A derivative of dGTP | 700 µg | 38820-700 | More Info |
| 2'(3')-O-(5-Chloroanthraniloyl)guanosine-5'-O-triphosphate (sodium salt) | GTP derivatives | 700 µg | 38821-700 | More Info |
| 2'(3')-O-(5-Chloroanthraniloyl)inosine-5'-O-triphosphate (sodium salt) | Fluorescent ITP derivatives; selectively inhibits mammalian AC1, AC2, and… | 3.3 mg | 38450-33 | More Info |
| Ochratoxin A | A mycotoxin; increases lipid peroxide levels and the number of apoptotic c… | 1 mg | 11439-1 | More Info |
| Ochratoxin A | A mycotoxin; increases lipid peroxide levels and the number of apoptotic c… | 10 mg | 11439-10 | More Info |
| Ochratoxin A | A mycotoxin; increases lipid peroxide levels and the number of apoptotic c… | 5 mg | 11439-5 | More Info |
| Ochratoxin A-13C20 | An internal standard for the quantification of ochratoxin A by GC- or LC-MS | 1.2 mL | 31295-12 | More Info |
| Ochratoxin B | A non-chlorinated analog of OTA that has cytotoxic effects on kidney and l… | 1 mg | 16167-1 | More Info |
| Ochratoxin B | A non-chlorinated analog of OTA that has cytotoxic effects on kidney and l… | 5 mg | 16167-5 | More Info |
| Ochratoxin B | A non-chlorinated analog of OTA that has cytotoxic effects on kidney and l… | 500 µg | 16167-500 | More Info |
| Ochratoxin B-13C20 | An internal standard for the quantification of ochratoxin B by GC- or LC-MS | 1.2 mL | 40238-12 | More Info |
| Ochratoxin C | The ethyl ester analog of ochratoxin A | 1 mg | 20183-1 | More Info |
| Ochratoxin C | The ethyl ester analog of ochratoxin A | 5 mg | 20183-5 | More Info |
| Ochratoxin C-13C20 | An internal standard for the quantification of ochratoxin C by GC- or LC-MS | 1.2 mL | 40239-12 | More Info |
| Ocinaplon | A GABAA receptor allosteric agonist; potentiates GABA-induced currents in… | 10 mg | 37478-10 | More Info |
| Ocinaplon | A GABAA receptor allosteric agonist; potentiates GABA-induced currents in… | 25 mg | 37478-25 | More Info |
| Ocinaplon | A GABAA receptor allosteric agonist; potentiates GABA-induced currents in… | 5 mg | 37478-5 | More Info |
| Ocinaplon | A GABAA receptor allosteric agonist; potentiates GABA-induced currents in… | 50 mg | 37478-50 | More Info |
| OC2-K3-E10 | An ionizable cationic lipid (pKa = 6.8); has been used in the formation of… | 1 mg | 38243-1 | More Info |
| OC2-K3-E10 | An ionizable cationic lipid (pKa = 6.8); has been used in the formation of… | 10 mg | 38243-10 | More Info |
| OC2-K3-E10 | An ionizable cationic lipid (pKa = 6.8); has been used in the formation of… | 5 mg | 38243-5 | More Info |
| OC2-K3-E10 | An ionizable cationic lipid (pKa = 6.8); has been used in the formation of… | 50 mg | 38243-50 | More Info |
| Oclacitinib | A JAK family kinase inhibitor (IC50s = 10, 18, 99, and 84 nM for JAK1, JAK… | 1 mg | 18722-1 | More Info |
| Oclacitinib | A JAK family kinase inhibitor (IC50s = 10, 18, 99, and 84 nM for JAK1, JAK… | 10 mg | 18722-10 | More Info |
| Oclacitinib | A JAK family kinase inhibitor (IC50s = 10, 18, 99, and 84 nM for JAK1, JAK… | 5 mg | 18722-5 | More Info |
| Oclacitinib | A JAK family kinase inhibitor (IC50s = 10, 18, 99, and 84 nM for JAK1, JAK… | 50 mg | 18722-50 | More Info |
| Oclacitinib-13C-d3 | An internal standard for the quantification of oclacitinib by GC- or LC-MS | 1 mg | 28808-1 | More Info |
| Oclacitinib-13C-d3 | An internal standard for the quantification of oclacitinib by GC- or LC-MS | 500 µg | 28808-500 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile